Moderate-Intensity Rosuvastatin Plus Ezetimibe Versus High-Intensity Rosuvastatin for Target Low-Density Lipoprotein Cholesterol Goal Achievement in Patients With Recent Ischemic Stroke: A Randomized Controlled Trial.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of stroke"
DOI: 10.5853/jos.2022.02957
Abstract: Background and Purpose Moderate-intensity statin plus ezetimibe versus high-intensity statin alone may provide a greater low-density lipoprotein cholesterol (LDL-C) reduction in patients with recent ischemic stroke. Methods This randomized, open-label, controlled trial assigned patients with… read more here.
Keywords: patients recent; intensity rosuvastatin; recent ischemic; intensity ... See more keywords